CLINICAL_TRIALS
research
· 2009-03-03
Clinical Trial Update: A Double Blind Placebo Control Study to Assess the Safety,Tolerability and Efficacy of Copaxone in Crohn's Disease [Phase 2]
Summary
This document reports a Phase 2 double-blind, placebo-controlled trial of Copaxone (glatiramer acetate) in Crohn's disease. The study aims to assess safety, tol…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Crohns Disease | Phase 2 | Status: UNKNOWN